Goldman Sachs
PHVS icon

Goldman Sachs’s Pharvaris PHVS Stock Holding History

Goldman Sachs’s Portfolio PHVS Stock Details PHVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.04M Sell
142,929
-17,981
-11% -$480K ﹤0.01% 3922
2025
Q4 		$4.47M Buy
160,910
+146,434
+1,012% +$3.53M ﹤0.01% 3856
2025
Q3 		$361K Buy
+14,476
New +$321K ﹤0.01% 5669
2025
Q1 		– Sell
-44,247
Closed -$848K – 6336
2024
Q4 		$848K Sell
44,247
-19,583
-31% -$403K ﹤0.01% 4933
2024
Q3 		$1.18M Buy
63,830
+2,360
+4% +$43.1K ﹤0.01% 4529
2024
Q2 		$1.16M Buy
61,470
+30,354
+98% +$618K ﹤0.01% 4339
2024
Q1 		$719K Buy
31,116
+22,567
+264% +$599K ﹤0.01% 4546
2023
Q4 		$240K Buy
+8,549
New +$173K ﹤0.01% 5089
2022
Q4 		– Sell
-56,606
Closed -$434K – 6205
2022
Q3 		$434K Sell
56,606
-345
-0.6% -$5.39K ﹤0.01% 5066
2022
Q2 		$1.26M Buy
56,951
+1,115
+2% +$20.8K ﹤0.01% 4433
2022
Q1 		$1.01M Sell
55,836
-1,680
-3% -$29.6K ﹤0.01% 4805
2021
Q4 		$828K Buy
57,516
+27,342
+91% +$427K ﹤0.01% 5009
2021
Q3 		$535K Buy
30,174
+2,382
+9% +$40.8K ﹤0.01% 5153
2021
Q2 		$518K Buy
27,792
+3,364
+14% +$76.4K ﹤0.01% 5194
2021
Q1 		$683K Buy
+24,428
New +$769K ﹤0.01% 4894

Other funds holding PHVS

GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
EFM
EQT Fund Management Luxembourg $1.02B AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Goldman Sachs's PHVS Position: Q1 2026 in Review

Goldman Sachs reduced its Pharvaris (PHVS) stake by 11% in Q1 2026, selling an estimated $480K and leaving 142,929 shares worth $4.04M. The position accounts for ﹤0.01% of the portfolio, ranked #3922.

Goldman Sachs first reported a position in PHVS in Q1 2021 and has held it in 15 quarters since. The position peaked at $4.47M in Q4 2025. 110 funds tracked by Wall St. Rank hold PHVS as of Q1 2026.

  • Goldman Sachs held 142,929 shares of Pharvaris worth $4.04M as of Q1 2026.
  • Goldman Sachs sold 17,981 Pharvaris shares in Q1 2026, an estimated $480K.
  • Pharvaris made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #3922 holding.
  • Goldman Sachs first reported a position in Pharvaris in Q1 2021 and has held it in 15 quarters since.
  • Goldman Sachs's Pharvaris position peaked at $4.47M in Q4 2025.
  • 110 funds tracked by Wall St. Rank held Pharvaris as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.